Provider: NIHR Journals Library
Content:text/plain; charset="UTF-8"
TY  - JOUR
LB  - 1.
AU  - Svedbom, A
AU  - Hernlund, E
AU  - Ivergård, M
AU  - Compston, J
AU  - Cooper, C
AU  - Stenmark, J
TI  - Osteoporosis in the European Union: a compendium of country-specific reports
J2  - Arch Osteoporos
PY  - 2013
VL  - 8
SP  - 137
UR  - https://doi.org/10.1007/s11657-013-0137-0
ER  - 
TY  - JOUR
LB  - 2.
AU  - Lubwama, R
AU  - Nguyen, A
AU  - Modi, A
AU  - Chirovsky, D
AU  - Miller, PD
TI  - Prevalence of renal impairment among osteoporotic women in the USA, NHANES 2005–2008: is treatment with bisphosphonates an option?
J2  - Osteoporos Int
PY  - 2014
VL  - 25
SP  - 1607
EP  - 1615
UR  - https://doi.org/10.1007/s00198-014-2645-1
ER  - 
TY  - JOUR
LB  - 3.
AU  - Gifford, FJ
AU  - Methven, S
AU  - Boag, DE
AU  - Spalding, EM
AU  - Macgregor, MS
TI  - Chronic kidney disease prevalence and secular trends in a UK population: the impact of MDRD and CKD-EPI formulae
J2  - QJM
PY  - 2011
VL  - 104
SP  - 1045
EP  - 1053
UR  - https://doi.org/10.1093/qjmed/hcr122
ER  - 
TY  - JOUR
LB  - 4.
AU  - Jamal, SA
AU  - Swan, VJ
AU  - Brown, JP
AU  - Hanley, DA
AU  - Prior, JC
AU  - Papaioannou, A
TI  - Kidney function and rate of bone loss at the hip and spine: the Canadian Multicentre Osteoporosis Study
J2  - Am J Kidney Dis
PY  - 2010
VL  - 55
SP  - 291
EP  - 299
UR  - https://doi.org/10.1053/j.ajkd.2009.10.049
ER  - 
TY  - JOUR
LB  - 5.
AU  - Nickolas, TL
AU  - McMahon, DJ
AU  - Shane, E
TI  - Relationship between moderate to severe kidney disease and hip fracture in the United States
J2  - J Am Soc Nephrol
PY  - 2006
VL  - 17
SP  - 3223
EP  - 3232
UR  - https://doi.org/10.1681/ASN.2005111194
ER  - 
TY  - JOUR
LB  - 6.
AU  - Ensrud, KE
AU  - Lui, LY
AU  - Taylor, BC
AU  - Ishani, A
AU  - Shlipak, MG
AU  - Stone, KL
TI  - Renal function and risk of hip and vertebral fractures in older women
J2  - Arch Intern Med
PY  - 2007
VL  - 167
SP  - 133
EP  - 139
UR  - https://doi.org/10.1001/archinte.167.2.133
ER  - 
TY  - JOUR
LB  - 7.
AU  - Dooley, AC
AU  - Weiss, NS
AU  - Kestenbaum, B
TI  - Increased risk of hip fracture among men with CKD
J2  - Am J Kidney Dis
PY  - 2008
VL  - 51
SP  - 38
EP  - 44
UR  - https://doi.org/10.1053/j.ajkd.2007.08.019
ER  - 
TY  - JOUR
LB  - 8.
AU  - Alem, AM
AU  - Sherrard, DJ
AU  - Gillen, DL
AU  - Weiss, NS
AU  - Beresford, SA
AU  - Heckbert, SR
TI  - Increased risk of hip fracture among patients with end-stage renal disease
J2  - Kidney Int
PY  - 2000
VL  - 58
SP  - 396
EP  - 399
UR  - https://doi.org/10.1046/j.1523-1755.2000.00178.x
ER  - 
TY  - JOUR
LB  - 9.
AU  - Chennuru, S
AU  - Koduri, J
AU  - Baumann, MA
TI  - Risk factors for symptomatic hypocalcaemia complicating treatment with zoledronic acid
J2  - Intern Med J
PY  - 2008
VL  - 38
SP  - 635
EP  - 637
UR  - https://doi.org/10.1111/j.1445-5994.2007.01580.x
ER  - 
TY  - JOUR
LB  - 10.
AU  - Miller, PD
TI  - Fragility fractures in chronic kidney disease: an opinion-based approach
J2  - Cleve Clin J Med
PY  - 2009
VL  - 76
SP  - 715
EP  - 723
UR  - https://doi.org/10.3949/ccjm.76a.08108
ER  - 
TY  - JOUR
LB  - 11.
AU  - Miller, PD
AU  - Roux, C
AU  - Boonen, S
AU  - Barton, IP
AU  - Dunlap, LE
AU  - Burgio, DE
TI  - Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials
J2  - J Bone Miner Res
PY  - 2005
VL  - 20
SP  - 2105
EP  - 2115
UR  - https://doi.org/10.1359/JBMR.050817
ER  - 
TY  - JOUR
LB  - 12.
AU  - Reyes, C
AU  - Pottegård, A
AU  - Schwarz, P
AU  - Javaid, MK
AU  - Van Staa, TP
AU  - Cooper, C
TI  - Real-life and RCT participants: alendronate users versus FITs’ trial eligibility criterion
J2  - Calcif Tissue Int
PY  - 2016
VL  - 99
SP  - 243
EP  - 249
UR  - https://doi.org/10.1007/s00223-016-0141-7
ER  - 
TY  - JOUR
LB  - 13.
AU  - Couttenye, MM
AU  - D’Haese, PC
AU  - Deng, JT
AU  - Van Hoof, VO
AU  - Verpooten, GA
AU  - De Broe, ME
TI  - High prevalence of adynamic bone disease diagnosed by biochemical markers in a wide sample of the European CAPD population
J2  - Nephrol Dial Transplant
PY  - 1997
VL  - 12
SP  - 2144
EP  - 2150
UR  - https://doi.org/10.1093/ndt/12.10.2144
ER  - 
TY  - JOUR
LB  - 14.
AU  - Monier-Faugere, MC
AU  - Mawad, H
AU  - Qi, Q
AU  - Friedler, RM
AU  - Malluche, HH
TI  - High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation
J2  - J Am Soc Nephrol
PY  - 2000
VL  - 11
SP  - 1093
EP  - 1099
ER  - 
TY  - JOUR
LB  - 15.
AU  - Ott, SM
TI  - Bone histomorphometry in renal osteodystrophy
J2  - Semin Nephrol
PY  - 2009
VL  - 29
SP  - 122
EP  - 132
UR  - https://doi.org/10.1016/j.semnephrol.2009.01.005
ER  - 
TY  - JOUR
LB  - 16.
AU  - Wilson, LM
AU  - Rebholz, CM
AU  - Jirru, E
AU  - Liu, MC
AU  - Zhang, A
AU  - Gayleard, J
TI  - Benefits and harms of osteoporosis medications in patients with chronic kidney disease: a systematic review and meta-analysis
J2  - Ann Intern Med
PY  - 2017
VL  - 166
SP  - 649
EP  - 658
UR  - https://doi.org/10.7326/M16-2752
ER  - 
TY  - JOUR
LB  - 17.
AU  - Jamal, SA
AU  - Bauer, DC
AU  - Ensrud, KE
AU  - Cauley, JA
AU  - Hochberg, M
AU  - Ishani, A
AU  - Cummings, SR
TI  - Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial
J2  - J Bone Miner Res
PY  - 2007
VL  - 22
SP  - 503
EP  - 508
UR  - https://doi.org/10.1359/jbmr.070112
ER  - 
TY  - ELEC
LB  - 18.
AU  - National Institute for Health and Care Excellence
TI  - Raloxifene for the Primary Prevention of Osteoporotic Fragility Fractures in Postmenopausal Women
UR  - www.nice.org.uk/guidance/ta160
M1  - 12 July 2012
ER  - 
TY  - ELEC
LB  - 19.
AU  - National Institute for Health and Care Excellence
TI  - Raloxifene and Teriparatide for the Secondary Prevention of Osteoporotic Fragility Fractures in Postmenopausal Women
UR  - www.nice.org.uk/guidance/ta161
M1  - 12 July 2019
ER  - 
TY  - ELEC
LB  - 20.
AU  - Electronic Medicines Compendium
TI  - Fosamax Once Weekly 70 mg Tablets: Summary of Product Characteristics
UR  - www.medicines.org.uk/emc/product/1281/smpc
M1  - April 2018
ER  - 
TY  - ELEC
LB  - 21.
AU  - Electronic Medicines Compendium
TI  - Bonviva 150 mg Film-coated Tablets: Summary of Product Characteristics
UR  - www.medicines.org.uk/emc/product/9383/smpc
M1  - April 2018
ER  - 
TY  - ELEC
LB  - 22.
AU  - Electronic Medicines Compendium
TI  - Actonel 30 mg Film-coated Tablets: Summary of Product Characteristics
UR  - www.medicines.org.uk/emc/product/3836/smpc
M1  - April 2018
ER  - 
TY  - JOUR
LB  - 23.
AU  - Saleem, S
AU  - Patel, S
AU  - Ahmed, A
AU  - Saleem, N
TI  - Denosumab causing severe, refractory hypocalcaemia in a patient with chronic kidney disease
J2  - BMJ Case Rep
PY  - 2018
VL  - 2018
UR  - https://doi.org/10.1136/bcr-2017-224068
ER  - 
TY  - JOUR
LB  - 24.
AU  - Salim, SA
AU  - Nair, LR
AU  - Thomas, L
AU  - Garla, V
AU  - Palabindala, V
AU  - Agarwal, M
AU  - Fülöp, T
TI  - Denosumab-associated severe hypocalcemia in a patient with chronic kidney disease
J2  - Am J Med Sci
PY  - 2018
VL  - 355
SP  - 506
EP  - 509
UR  - https://doi.org/10.1016/j.amjms.2017.09.008
ER  - 
TY  - JOUR
LB  - 25.
AU  - Kostine, M
AU  - Mehsen-Cetre, N
AU  - Bannwarth, B
TI  - Denosumab-induced severe hypocalcemia in a patient with Paget’s disease of bone and impaired renal function
J2  - Therapie
PY  - 2017
VL  - 72
SP  - 383
EP  - 385
UR  - https://doi.org/10.1016/j.therap.2016.07.003
ER  - 
TY  - JOUR
LB  - 26.
AU  - Huynh, AL
AU  - Baker, ST
AU  - Stewardson, AJ
AU  - Johnson, DF
TI  - Denosumab-associated hypocalcaemia: incidence, severity and patient characteristics in a tertiary hospital setting
J2  - Pharmacoepidemiol Drug Saf
PY  - 2016
VL  - 25
SP  - 1274
EP  - 1278
UR  - https://doi.org/10.1002/pds.4045
ER  - 
TY  - JOUR
LB  - 27.
AU  - Isakova, T
AU  - Nickolas, TL
AU  - Denburg, M
AU  - Yarlagadda, S
AU  - Weiner, DE
AU  - Gutiérrez, OM
TI  - KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)
J2  - Am J Kidney Dis
PY  - 2017
VL  - 70
SP  - 737
EP  - 751
UR  - https://doi.org/10.1053/j.ajkd.2017.07.019
ER  - 
TY  - JOUR
LB  - 28.
AU  - Nitta, K
AU  - Yajima, A
AU  - Tsuchiya, K
TI  - Management of osteoporosis in chronic kidney disease
J2  - Intern Med
PY  - 2017
VL  - 56
SP  - 3271
EP  - 3276
UR  - https://doi.org/10.2169/internalmedicine.8618-16
ER  - 
TY  - JOUR
LB  - 29.
AU  - Herrett, E
AU  - Gallagher, AM
AU  - Bhaskaran, K
AU  - Forbes, H
AU  - Mathur, R
AU  - van Staa, T
AU  - Smeeth, L
TI  - Data resource profile: Clinical Practice Research Datalink (CPRD)
J2  - Int J Epidemiol
PY  - 2015
VL  - 44
SP  - 827
EP  - 836
UR  - https://doi.org/10.1093/ije/dyv098
ER  - 
TY  - JOUR
LB  - 30.
AU  - Benson, T
TI  - The history of the Read Codes: the inaugural James Read Memorial Lecture 2011
J2  - Inform Prim Care
PY  - 2011
VL  - 19
SP  - 173
EP  - 182
UR  - https://doi.org/10.14236/jhi.v19i3.811
ER  - 
TY  - JOUR
LB  - 31.
AU  - Judge, A
AU  - Javaid, MK
AU  - Leal, J
AU  - Hawley, S
AU  - Drew, S
AU  - Sheard, S
TI  - Models of care for the delivery of secondary fracture prevention after hip fracture: a health service cost, clinical outcomes and cost-effectiveness study within a region of England
J2  - Health Serv Deliv Res
PY  - 2016
VL  - 4
IS  - 28
UR  - https://doi.org/10.3310/hsdr04280
ER  - 
TY  - JOUR
LB  - 32.
AU  - Kynaston-Pearson, F
AU  - Ashmore, AM
AU  - Malak, TT
AU  - Rombach, I
AU  - Taylor, A
AU  - Beard, D
TI  - Primary hip replacement prostheses and their evidence base: systematic review of literature
J2  - BMJ
PY  - 2013
VL  - 347
SP  - f6956
UR  - https://doi.org/10.1136/bmj.f6956
ER  - 
TY  - JOUR
LB  - 33.
AU  - Tomlinson, LA
AU  - Riding, AM
AU  - Payne, RA
AU  - Abel, GA
AU  - Tomson, CR
AU  - Wilkinson, IB
TI  - The accuracy of diagnostic coding for acute kidney injury in England – a single centre study
J2  - BMC Nephrol
PY  - 2013
VL  - 14
SP  - 58
UR  - https://doi.org/10.1186/1471-2369-14-58
ER  - 
TY  - JOUR
LB  - 34.
AU  - Fotheringham, J
AU  - Fogarty, D
AU  - Jacques, R
AU  - El Nahas, M
AU  - Campbell, M
TI  - Chapter 13 The linkage of incident renal replacement therapy patients in England (2002–2006) to hospital episodes and national mortality data: improved demography and hospitalisation data in patients undergoing renal replacement therapy
J2  - Nephron Clin Pract
PY  - 2012
VL  - 120
IS  - Suppl. 1
SP  - c247
EP  - c260
UR  - https://doi.org/10.1159/000342857
ER  - 
TY  - ELEC
LB  - 35.
AU  - World Health Organization
TI  - International Classification of Diseases
ET  - 10th
CY  - Geneva
PB  - World Health Organization
UR  - www.who.int/classifications/icd/icdonlineversions/en/
M1  - 17 September 2019
ER  - 
TY  - ELEC
LB  - 36.
AU  - NHS Digital
TI  - NHS Classifications OPCS-4
UR  - https://isd.digital.nhs.uk/trud3/user/guest/group/0/pack/10
M1  - 17 September 2019
ER  - 
TY  - JOUR
LB  - 37.
AU  - Laulund, AS
AU  - Nybo, M
AU  - Brix, TH
AU  - Abrahamsen, B
AU  - Jørgensen, HL
AU  - Hegedüs, L
TI  - Duration of thyroid dysfunction correlates with all-cause mortality. the OPENTHYRO Register Cohort
J2  - PLOS ONE
PY  - 2014
VL  - 9
SP  - e110437
UR  - https://doi.org/10.1371/journal.pone.0110437
ER  - 
TY  - GEN
LB  - 38.
AU  - European Union
TI  - Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the Protection of Natural Persons with regard to the Processing of Personal Data and on the Free Movement of Such Data, and Repealing Directive 95/46/EC (General Data Protection Regulation) (OJ L 119 4.5.2016 p. 1–88)
CY  - Brussels
PB  - European Union
PY  - 2016
ER  - 
TY  - JOUR
LB  - 39.
AU  - Suissa, S
TI  - Immortal time bias in pharmaco-epidemiology
J2  - Am J Epidemiol
PY  - 2008
VL  - 167
SP  - 492
EP  - 499
UR  - https://doi.org/10.1093/aje/kwm324
ER  - 
TY  - JOUR
LB  - 40.
AU  - Lévesque, LE
AU  - Hanley, JA
AU  - Kezouh, A
AU  - Suissa, S
TI  - Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes
J2  - BMJ
PY  - 2010
VL  - 340
SP  - b5087
UR  - https://doi.org/10.1136/bmj.b5087
ER  - 
TY  - JOUR
LB  - 41.
AU  - Prieto-Alhambra, D
AU  - Javaid, MK
AU  - Judge, A
AU  - Maskell, J
AU  - Cooper, C
AU  - Arden, NK
AU  - COASt Study Group
TI  - Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study
J2  - Ann Rheum Dis
PY  - 2015
VL  - 74
SP  - 557
EP  - 563
UR  - https://doi.org/10.1136/annrheumdis-2013-204043
ER  - 
TY  - JOUR
LB  - 42.
AU  - Vestergaard, P
AU  - Prieto-Alhambra, D
AU  - Javaid, MK
AU  - Cooper, C
TI  - Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose
J2  - Osteoporos Int
PY  - 2013
VL  - 24
SP  - 671
EP  - 680
UR  - https://doi.org/10.1007/s00198-012-2043-5
ER  - 
TY  - JOUR
LB  - 43.
AU  - Prieto-Alhambra, D
AU  - Lalmohamed, A
AU  - Abrahamsen, B
AU  - Arden, NK
AU  - de Boer, A
AU  - Vestergaard, P
AU  - de Vries, F
TI  - Oral bisphosphonate use and total knee/hip implant survival: validation of results in an external population-based cohort
J2  - Arthritis Rheum
PY  - 2014
VL  - 66
SP  - 3233
EP  - 3240
UR  - https://doi.org/10.1002/art.38789
ER  - 
TY  - JOUR
LB  - 44.
AU  - Zhou, Z
AU  - Rahme, E
AU  - Abrahamowicz, M
AU  - Pilote, L
TI  - Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods
J2  - Am J Epidemiol
PY  - 2005
VL  - 162
SP  - 1016
EP  - 1023
UR  - https://doi.org/10.1093/aje/kwi307
ER  - 
TY  - JOUR
LB  - 45.
AU  - Klebe, B
AU  - Farmer, C
AU  - Cooley, R
AU  - de Lusignan, S
AU  - Middleton, R
AU  - O’Donoghue, D
TI  - Kidney disease management in UK primary care: guidelines, incentives and information technology
J2  - Fam Pract
PY  - 2007
VL  - 24
SP  - 330
EP  - 335
UR  - https://doi.org/10.1093/fampra/cmm026
ER  - 
TY  - JOUR
LB  - 46.
AU  - Levey, AS
AU  - Stevens, LA
AU  - Schmid, CH
AU  - Zhang, YL
AU  - Castro, AF
AU  - Feldman, HI
TI  - A new equation to estimate glomerular filtration rate
J2  - Ann Intern Med
PY  - 2009
VL  - 150
SP  - 604
EP  - 612
UR  - https://doi.org/10.7326/0003-4819-150-9-200905050-00006
ER  - 
TY  - JOUR
LB  - 47.
AU  - Williamson, EJ
AU  - Forbes, A
TI  - Introduction to propensity scores
J2  - Respirology
PY  - 2014
VL  - 19
SP  - 625
EP  - 635
UR  - https://doi.org/10.1111/resp.12312
ER  - 
TY  - JOUR
LB  - 48.
AU  - Westreich, D
AU  - Cole, SR
AU  - Funk, MJ
AU  - Brookhart, MA
AU  - Stürmer, T
TI  - The role of the c-statistic in variable selection for propensity score models
J2  - Pharmacoepidemiol Drug Saf
PY  - 2011
VL  - 20
SP  - 317
EP  - 320
UR  - https://doi.org/10.1002/pds.2074
ER  - 
TY  - JOUR
LB  - 49.
AU  - Austin, PC
TI  - The performance of different propensity-score methods for estimating relative risks
J2  - J Clin Epidemiol
PY  - 2008
VL  - 61
SP  - 537
EP  - 545
UR  - https://doi.org/10.1016/j.jclinepi.2007.07.011
ER  - 
TY  - JOUR
LB  - 50.
AU  - Nguyen, TL
AU  - Collins, GS
AU  - Spence, J
AU  - Daurès, JP
AU  - Devereaux, PJ
AU  - Landais, P
AU  - Le Manach, Y
TI  - Double-adjustment in propensity score matching analysis: choosing a threshold for considering residual imbalance
J2  - BMC Med Res Methodol
PY  - 2017
VL  - 17
SP  - 78
UR  - https://doi.org/10.1186/s12874-017-0338-0
ER  - 
TY  - JOUR
LB  - 51.
AU  - Brookhart, MA
AU  - Schneeweiss, S
AU  - Rothman, KJ
AU  - Glynn, RJ
AU  - Avorn, J
AU  - Stürmer, T
TI  - Variable selection for propensity score models
J2  - Am J Epidemiol
PY  - 2006
VL  - 163
SP  - 1149
EP  - 1156
UR  - https://doi.org/10.1093/aje/kwj149
ER  - 
TY  - JOUR
LB  - 52.
AU  - Leyrat, C
AU  - Seaman, SR
AU  - White, IR
AU  - Douglas, I
AU  - Smeeth, L
AU  - Kim, J
TI  - Propensity score analysis with partially observed covariates: how should multiple imputation be used?
J2  - Stat Methods Med Res
PY  - 2017
VL  - 0
UR  - https://doi.org/10.1177/0962280217713032
ER  - 
TY  - JOUR
LB  - 53.
AU  - Green, JR
AU  - Seltenmeyer, Y
AU  - Jaeggi, KA
AU  - Widler, L
TI  - Renal tolerability profile of novel, potent bisphosphonates in two short-term rat models
J2  - Pharmacol Toxicol
PY  - 1997
VL  - 80
SP  - 225
EP  - 230
UR  - https://doi.org/10.1111/j.1600-0773.1997.tb01964.x
ER  - 
TY  - JOUR
LB  - 54.
AU  - Cal, JC
AU  - Daley-Yates, PT
TI  - Disposition and nephrotoxicity of 3-amino-1-hydroxypropylidene-1, 1-bisphosphonate (APD), in rats and mice
J2  - Toxicology
PY  - 1990
VL  - 65
SP  - 179
EP  - 197
UR  - https://doi.org/10.1016/0300-483X(90)90088-X
ER  - 
TY  - JOUR
LB  - 55.
AU  - Braun, JP
AU  - Rico, AG
AU  - Benard, P
AU  - Burgat-Sacaze, V
AU  - Eghbali, B
AU  - Godfrain, JC
TI  - Urinary gamma-glutamyl transferase in renal toxicology of the rat. Bases of its use and significance in acute mercurial nephritis
J2  - Toxicology
PY  - 1978
VL  - 11
SP  - 73
EP  - 82
UR  - https://doi.org/10.1016/S0300-483X(78)90539-5
ER  - 
TY  - JOUR
LB  - 56.
AU  - Bauss, F
AU  - Russell, RG
TI  - Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosing
J2  - Osteoporos Int
PY  - 2004
VL  - 15
SP  - 423
EP  - 433
UR  - https://doi.org/10.1007/s00198-004-1612-7
ER  - 
TY  - JOUR
LB  - 57.
AU  - Pfister, T
AU  - Atzpodien, E
AU  - Bohrmann, B
AU  - Bauss, F
TI  - Acute renal effects of intravenous bisphosphonates in the rat
J2  - Basic Clin Pharmacol Toxicol
PY  - 2005
VL  - 97
SP  - 374
EP  - 381
UR  - https://doi.org/10.1111/j.1742-7843.2005.pto_160.x
ER  - 
TY  - JOUR
LB  - 58.
AU  - Markowitz, GS
AU  - Appel, GB
AU  - Fine, PL
AU  - Fenves, AZ
AU  - Loon, NR
AU  - Jagannath, S
TI  - Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate
J2  - J Am Soc Nephrol
PY  - 2001
VL  - 12
SP  - 1164
EP  - 1172
ER  - 
TY  - JOUR
LB  - 59.
AU  - Barri, YM
AU  - Munshi, NC
AU  - Sukumalchantra, S
AU  - Abulezz, SR
AU  - Bonsib, SM
AU  - Wallach, J
AU  - Walker, PD
TI  - Podocyte injury associated glomerulopathies induced by pamidronate
J2  - Kidney Int
PY  - 2004
VL  - 65
SP  - 634
EP  - 641
UR  - https://doi.org/10.1111/j.1523-1755.2004.00426.x
ER  - 
TY  - JOUR
LB  - 60.
AU  - Desikan, R
AU  - Veksler, Y
AU  - Raza, S
AU  - Stokes, B
AU  - Sabir, T
AU  - Li, ZJ
AU  - Jagannath, S
TI  - Nephrotic proteinuria associated with high-dose pamidronate in multiple myeloma
J2  - Br J Haematol
PY  - 2002
VL  - 119
SP  - 496
EP  - 499
UR  - https://doi.org/10.1046/j.1365-2141.2002.03826.x
ER  - 
TY  - JOUR
LB  - 61.
AU  - Shreedhara, M
AU  - Fenves, AZ
AU  - Benavides, D
AU  - Stone, MJ
TI  - Reversibility of pamidronate-associated glomerulosclerosis
J2  - Proc
PY  - 2007
VL  - 20
SP  - 249
EP  - 253
UR  - https://doi.org/10.1080/08998280.2007.11928298
ER  - 
TY  - JOUR
LB  - 62.
AU  - Markowitz, GS
AU  - Fine, PL
AU  - D’Agati, VD
TI  - Nephrotic syndrome after treatment with pamidronate
J2  - Am J Kidney Dis
PY  - 2002
VL  - 39
SP  - 1118
EP  - 1122
UR  - https://doi.org/10.1053/ajkd.2002.32797
ER  - 
TY  - JOUR
LB  - 63.
AU  - Kunin, M
AU  - Kopolovic, J
AU  - Avigdor, A
AU  - Holtzman, EJ
TI  - Collapsing glomerulopathy induced by long-term treatment with standard-dose pamidronate in a myeloma patient
J2  - Nephrol Dial Transplant
PY  - 2004
VL  - 19
SP  - 723
EP  - 726
UR  - https://doi.org/10.1093/ndt/gfg567
ER  - 
TY  - JOUR
LB  - 64.
AU  - Lockridge, L
AU  - Papac, RJ
AU  - Perazella, MA
TI  - Pamidronate-associated nephrotoxicity in a patient with Langerhans’s histiocytosis
J2  - Am J Kidney Dis
PY  - 2002
VL  - 40
SP  - E2
UR  - https://doi.org/10.1053/ajkd.2002.33933
ER  - 
TY  - JOUR
LB  - 65.
AU  - Nasr, SH
AU  - Preddie, DC
AU  - Markowitz, GS
AU  - Appel, GB
AU  - D’Agati, VD
TI  - Multiple myeloma, nephrotic syndrome and crystalloid inclusions in podocytes
J2  - Kidney Int
PY  - 2006
VL  - 69
SP  - 616
EP  - 620
UR  - https://doi.org/10.1038/sj.ki.5000144
ER  - 
TY  - JOUR
LB  - 66.
AU  - Bodmer, M
AU  - Amico, P
AU  - Mihatsch, MJ
AU  - Haschke, M
AU  - Kummer, O
AU  - Krahenbuhl, S
TI  - Focal segmental glomerulosclerosis associated with long-term treatment with zoledronate in a myeloma patient
J2  - Nephrol Dial Transplant
PY  - 2007
VL  - 22
SP  - 2366
EP  - 2370
UR  - https://doi.org/10.1093/ndt/gfm209
ER  - 
TY  - JOUR
LB  - 67.
AU  - Black, DM
AU  - Delmas, PD
AU  - Eastell, R
AU  - Reid, IR
AU  - Boonen, S
AU  - Cauley, JA
TI  - Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
J2  - N Engl J Med
PY  - 2007
VL  - 356
SP  - 1809
EP  - 1822
UR  - https://doi.org/10.1056/NEJMoa067312
ER  - 
TY  - JOUR
LB  - 68.
AU  - Lyles, KW
AU  - Colón-Emeric, CS
AU  - Magaziner, JS
AU  - Adachi, JD
AU  - Pieper, CF
AU  - Mautalen, C
TI  - Zoledronic acid and clinical fractures and mortality after hip fracture
J2  - N Engl J Med
PY  - 2007
VL  - 357
SP  - 1799
EP  - 1809
UR  - https://doi.org/10.1056/NEJMoa074941
ER  - 
TY  - JOUR
LB  - 69.
AU  - Berenson, JR
AU  - Lichtenstein, A
AU  - Porter, L
AU  - Dimopoulos, MA
AU  - Bordoni, R
AU  - George, S
TI  - Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group
J2  - N Engl J Med
PY  - 1996
VL  - 334
SP  - 488
EP  - 493
UR  - https://doi.org/10.1056/NEJM199602223340802
ER  - 
TY  - JOUR
LB  - 70.
AU  - Lipton, A
AU  - Theriault, RL
AU  - Hortobagyi, GN
AU  - Simeone, J
AU  - Knight, RD
AU  - Mellars, K
TI  - Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials
J2  - Cancer
PY  - 2000
VL  - 88
SP  - 1082
EP  - 1090
UR  - https://doi.org/10.1002/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO;2-Z
ER  - 
TY  - JOUR
LB  - 71.
AU  - Rosen, LS
AU  - Gordon, D
AU  - Tchekmedyian, S
AU  - Yanagihara, R
AU  - Hirsh, V
AU  - Krzakowski, M
TI  - Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial – the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group
J2  - J Clin Oncol
PY  - 2003
VL  - 21
SP  - 3150
EP  - 3157
UR  - https://doi.org/10.1200/JCO.2003.04.105
ER  - 
TY  - JOUR
LB  - 72.
AU  - Nunn, AJ
AU  - Mwaba, P
AU  - Chintu, C
AU  - Mwinga, A
AU  - Darbyshire, JH
AU  - Zumla, A
AU  - UNZA-UCLMS Project, LUCOT
TI  - Collaboration. Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial
J2  - BMJ
PY  - 2008
VL  - 337
SP  - a257
UR  - https://doi.org/10.1136/bmj.a257
ER  - 
TY  - JOUR
LB  - 73.
AU  - Tilling, K
AU  - Macdonald-Wallis, C
AU  - Lawlor, DA
AU  - Hughes, RA
AU  - Howe, LD
TI  - Modelling childhood growth using fractional polynomials and linear splines
J2  - Ann Nutr Metab
PY  - 2014
VL  - 65
SP  - 129
EP  - 138
UR  - https://doi.org/10.1159/000362695
ER  - 
TY  - JOUR
LB  - 74.
AU  - Fine, JP
AU  - Gray, RJ
TI  - A proportional hazards model for the subdistribution of a competing risk
J2  - J Am Stat Assoc
PY  - 1999
VL  - 94
SP  - 496
EP  - 509
UR  - https://doi.org/10.1080/01621459.1999.10474144
ER  - 
TY  - JOUR
LB  - 75.
AU  - Hill, AB
TI  - The environment and disease: association or causation?
J2  - Proc R Soc Med
PY  - 1965
VL  - 58
SP  - 295
EP  - 300
UR  - https://doi.org/10.1177/003591576505800503
ER  - 
TY  - JOUR
LB  - 76.
AU  - Schneeweiss, S
TI  - Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics
J2  - Pharmacoepidemiol Drug Saf
PY  - 2006
VL  - 15
SP  - 291
EP  - 303
UR  - https://doi.org/10.1002/pds.1200
ER  - 
TY  - JOUR
LB  - 77.
AU  - Freemantle, N
AU  - Cooper, C
AU  - Diez-Perez, A
AU  - Gitlin, M
AU  - Radcliffe, H
AU  - Shepherd, S
TI  - Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis
J2  - Osteoporos Int
PY  - 2013
VL  - 24
SP  - 209
EP  - 217
UR  - https://doi.org/10.1007/s00198-012-2068-9
ER  - 
TY  - JOUR
LB  - 78.
AU  - Nayak, S
AU  - Greenspan, SL
TI  - Osteoporosis treatment efficacy for men: a systematic review and meta-analysis
J2  - J Am Geriatr Soc
PY  - 2017
VL  - 65
SP  - 490
EP  - 495
UR  - https://doi.org/10.1111/jgs.14668
ER  - 
TY  - JOUR
LB  - 79.
AU  - Miller, PD
AU  - Jamal, SA
AU  - Evenepoel, P
AU  - Eastell, R
AU  - Boonen, S
TI  - Renal safety in patients treated with bisphosphonates for osteoporosis: a review
J2  - J Bone Miner Res
PY  - 2013
VL  - 28
SP  - 2049
EP  - 2059
UR  - https://doi.org/10.1002/jbmr.2058
ER  - 
TY  - JOUR
LB  - 80.
AU  - Black, DM
AU  - Cummings, SR
AU  - Karpf, DB
AU  - Cauley, JA
AU  - Thompson, DE
AU  - Nevitt, MC
TI  - Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group
J2  - Lancet
PY  - 1996
VL  - 348
SP  - 1535
EP  - 1541
UR  - https://doi.org/10.1016/S0140-6736(96)07088-2
ER  - 
TY  - JOUR
LB  - 81.
AU  - Chesnut, CH
AU  - Skag, A
AU  - Christiansen, C
AU  - Recker, R
AU  - Stakkestad, JA
AU  - Hoiseth, A
TI  - Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis
J2  - J Bone Miner Res
PY  - 2004
VL  - 19
SP  - 1241
EP  - 1249
UR  - https://doi.org/10.1359/JBMR.040325
ER  - 
TY  - JOUR
LB  - 82.
AU  - Hawley, S
AU  - Leal, J
AU  - Delmestri, A
AU  - Prieto-Alhambra, D
AU  - Arden, NK
AU  - Cooper, C
TI  - Anti-osteoporosis medication prescriptions and incidence of subsequent fracture among primary hip fracture patients in England and Wales: an interrupted time-series analysis
J2  - J Bone Miner Res
PY  - 2016
VL  - 31
SP  - 2008
EP  - 2015
UR  - https://doi.org/10.1002/jbmr.2882
ER  - 
TY  - JOUR
LB  - 83.
AU  - Pimentel, A
AU  - Ureña-Torres, P
AU  - Zillikens, MC
AU  - Bover, J
AU  - Cohen-Solal, M
TI  - Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation
J2  - Kidney Int
PY  - 2017
VL  - 92
SP  - 1343
EP  - 1355
UR  - https://doi.org/10.1016/j.kint.2017.07.021
ER  - 
TY  - JOUR
LB  - 84.
AU  - Black, DM
AU  - Thompson, DE
AU  - Bauer, DC
AU  - Ensrud, K
AU  - Musliner, T
AU  - Hochberg, MC
TI  - Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group
J2  - J Clin Endocrinol Metab
PY  - 2000
VL  - 85
SP  - 4118
EP  - 4124
UR  - https://doi.org/10.1210/jcem.85.11.6953
ER  - 
TY  - JOUR
LB  - 85.
AU  - Suresh, E
AU  - Pazianas, M
AU  - Abrahamsen, B
TI  - Safety issues with bisphosphonate therapy for osteoporosis
J2  - Rheumatology
PY  - 2014
VL  - 53
SP  - 19
EP  - 31
UR  - https://doi.org/10.1093/rheumatology/ket236
ER  - 
TY  - JOUR
LB  - 86.
AU  - Lewiecki, EM
TI  - Safety of long-term bisphosphonate therapy for the management of osteoporosis
J2  - Drugs
PY  - 2011
VL  - 71
SP  - 791
EP  - 814
UR  - https://doi.org/10.2165/11585470-000000000-00000
ER  - 
TY  - JOUR
LB  - 87.
AU  - Chang, JT
AU  - Green, L
AU  - Beitz, J
TI  - Renal failure with the use of zoledronic acid
J2  - N Engl J Med
PY  - 2003
VL  - 349
SP  - 1676
EP  - 1679
UR  - https://doi.org/10.1056/NEJM200310233491721
ER  - 
TY  - JOUR
LB  - 88.
AU  - Munier, A
AU  - Gras, V
AU  - Andrejak, M
AU  - Bernard, N
AU  - Jean-Pastor, MJ
AU  - Gautier, S
TI  - Zoledronic acid and renal toxicity: data from French adverse effect reporting database
J2  - Ann Pharmacother
PY  - 2005
VL  - 39
SP  - 1194
EP  - 1197
UR  - https://doi.org/10.1345/aph.1E589
ER  - 
TY  - JOUR
LB  - 89.
AU  - Banerjee, D
AU  - Asif, A
AU  - Striker, L
AU  - Preston, RA
AU  - Bourgoignie, JJ
AU  - Roth, D
TI  - Short-term, high-dose pamidronate-induced acute tubular necrosis: the postulated mechanisms of bisphosphonate nephrotoxicity
J2  - Am J Kidney Dis
PY  - 2003
VL  - 41
SP  - E18
UR  - https://doi.org/10.1016/S0272-6386(03)00214-2
ER  - 
TY  - JOUR
LB  - 90.
AU  - Liaño, F
AU  - Pascual, J
TI  - Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group
J2  - Kidney Int
PY  - 1996
VL  - 50
SP  - 811
EP  - 818
UR  - https://doi.org/10.1038/ki.1996.380
ER  - 
TY  - JOUR
LB  - 91.
AU  - Pedersen, AB
AU  - Christiansen, CF
AU  - Gammelager, H
AU  - Kahlert, J
AU  - Sørensen, HT
TI  - Risk of acute renal failure and mortality after surgery for a fracture of the hip: a population-based cohort study
J2  - Bone Joint J
PY  - 2016
VL  - 98–B
SP  - 1112
EP  - 1118
UR  - https://doi.org/10.1302/0301-620X.98B8.37497
ER  - 
TY  - JOUR
LB  - 92.
AU  - Bauer, DC
AU  - Black, D
AU  - Ensrud, K
AU  - Thompson, D
AU  - Hochberg, M
AU  - Nevitt, M
TI  - Upper gastrointestinal tract safety profile of alendronate: the fracture intervention trial
J2  - Arch Intern Med
PY  - 2000
VL  - 160
SP  - 517
EP  - 525
UR  - https://doi.org/10.1001/archinte.160.4.517
ER  - 
TY  - JOUR
LB  - 93.
AU  - Peng, YL
AU  - Hu, HY
AU  - Luo, JC
AU  - Hou, MC
AU  - Lin, HC
AU  - Lee, FY
TI  - Alendronate, a bisphosphonate, increased upper and lower gastrointestinal bleeding: risk factor analysis from a nationwide population-based study
J2  - Osteoporos Int
PY  - 2014
VL  - 25
SP  - 1617
EP  - 1623
UR  - https://doi.org/10.1007/s00198-014-2647-z
ER  - 
TY  - JOUR
LB  - 94.
AU  - Recker, RR
AU  - Lewiecki, EM
AU  - Miller, PD
AU  - Reiffel, J
TI  - Safety of bisphosphonates in the treatment of osteoporosis
J2  - Am J Med
PY  - 2009
VL  - 122
IS  - Suppl. 2
SP  - 22
EP  - 32
UR  - https://doi.org/10.1016/j.amjmed.2008.12.004
ER  - 
TY  - JOUR
LB  - 95.
AU  - UK Renal Registry
TI  - Front & Back Matter
J2  - Nephron Clinical Practice
PY  - 2013
VL  - 125
SP  - 1
EP  - 4
UR  - https://doi.org/10.1159/000362374
ER  - 
TY  - ELEC
LB  - 96.
AU  - Nuffield Department of Orthopaedics, Rhuematology and Musculoskeletal Sciences
TI  - European Program of Post-Authorization Safety Studies for Protelos®/Osseor®through EU-ADR Alliance
UR  - www.ndorms.ox.ac.uk/research-groups/Musculoskeletal-Pharmacoepidemiology/ongoing-projects/european-program-of-post-authorisation-safety-studies-for-protelos-r-osseor-r-through-eu-adr-alliance
M1  - November 2018
ER  - 
TY  - JOUR
LB  - 97.
AU  - Cummings, SR
AU  - Black, DM
AU  - Nevitt, MC
AU  - Browner, W
AU  - Cauley, J
AU  - Ensrud, K
TI  - Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group
J2  - Lancet
PY  - 1993
VL  - 341
SP  - 72
EP  - 75
UR  - https://doi.org/10.1016/0140-6736(93)92555-8
ER  - 
TY  - JOUR
LB  - 98.
AU  - West, SL
AU  - Lok, CE
AU  - Langsetmo, L
AU  - Cheung, AM
AU  - Szabo, E
AU  - Pearce, D
TI  - Bone mineral density predicts fractures in chronic kidney disease
J2  - J Bone Miner Res
PY  - 2015
VL  - 30
SP  - 913
EP  - 919
UR  - https://doi.org/10.1002/jbmr.2406
ER  - 
TY  - JOUR
LB  - 99.
AU  - Hochberg, MC
AU  - Ross, PD
AU  - Black, D
AU  - Cummings, SR
AU  - Genant, HK
AU  - Nevitt, MC
TI  - Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group
J2  - Arthritis Rheum
PY  - 1999
VL  - 42
SP  - 1246
EP  - 1254
UR  - https://doi.org/10.1002/1529-0131(199906)42:6<1246::AID-ANR22>3.0.CO;2-U
ER  - 
TY  - JOUR
LB  - 100.
AU  - Schnitzer, T
AU  - Bone, HG
AU  - Crepaldi, G
AU  - Adami, S
AU  - McClung, M
AU  - Kiel, D
TI  - Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group
J2  - Aging
PY  - 2000
VL  - 12
SP  - 1
EP  - 12
UR  - https://doi.org/10.1007/BF03339822
ER  - 
TY  - JOUR
LB  - 101.
AU  - Orwoll, E
AU  - Ettinger, M
AU  - Weiss, S
AU  - Miller, P
AU  - Kendler, D
AU  - Graham, J
TI  - Alendronate for the treatment of osteoporosis in men
J2  - N Engl J Med
PY  - 2000
VL  - 343
SP  - 604
EP  - 610
UR  - https://doi.org/10.1056/NEJM200008313430902
ER  - 
TY  - JOUR
LB  - 102.
AU  - Saag, KG
AU  - Emkey, R
AU  - Schnitzer, TJ
AU  - Brown, JP
AU  - Hawkins, F
AU  - Goemaere, S
TI  - Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group
J2  - N Engl J Med
PY  - 1998
VL  - 339
SP  - 292
EP  - 299
UR  - https://doi.org/10.1056/NEJM199807303390502
ER  - 
TY  - JOUR
LB  - 103.
AU  - Cummings, SR
AU  - Palermo, L
AU  - Browner, W
AU  - Marcus, R
AU  - Wallace, R
AU  - Pearson, J
TI  - Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. Fracture Intervention Trial Research Group
J2  - JAMA
PY  - 2000
VL  - 283
SP  - 1318
EP  - 1321
UR  - https://doi.org/10.1001/jama.283.10.1318
ER  - 
TY  - JOUR
LB  - 104.
AU  - Iwasaki, Y
AU  - Kazama, JJ
AU  - Fukagawa, M
TI  - Molecular abnormalities underlying bone fragility in chronic kidney disease
J2  - Biomed Res Int
PY  - 2017
VL  - 2017
SP  - 3485785
UR  - https://doi.org/10.1155/2017/3485785
ER  - 
TY  - JOUR
LB  - 105.
AU  - Riggs, BL
AU  - Hodgson, SF
AU  - O’Fallon, WM
AU  - Chao, EY
AU  - Wahner, HW
AU  - Muhs, JM
TI  - Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis
J2  - N Engl J Med
PY  - 1990
VL  - 322
SP  - 802
EP  - 809
UR  - https://doi.org/10.1056/NEJM199003223221203
ER  - 
TY  - JOUR
LB  - 106.
AU  - Kinsella, S
AU  - Murphy, K
AU  - Breen, M
AU  - O’Neill, S
AU  - McLaughlin, P
AU  - Coyle, J
TI  - Comparison of single CT scan assessment of bone mineral density, vascular calcification and fat mass with standard clinical measurements in renal transplant subjects: the ABC HeART study
J2  - BMC Nephrol
PY  - 2015
VL  - 16
SP  - 188
UR  - https://doi.org/10.1186/s12882-015-0182-6
ER  - 
TY  - JOUR
LB  - 107.
AU  - Abrahamsen, B
AU  - Jørgensen, HL
AU  - Laulund, AS
AU  - Nybo, M
AU  - Brix, TH
AU  - Hegedüs, L
TI  - Low serum thyrotropin level and duration of suppression as a predictor of major osteoporotic fractures-the OPENTHYRO register cohort
J2  - J Bone Miner Res
PY  - 2014
VL  - 29
SP  - 2040
EP  - 2050
UR  - https://doi.org/10.1002/jbmr.2244
ER  - 
TY  - JOUR
LB  - 108.
AU  - Abrahamsen, B
AU  - Jørgensen, HL
AU  - Laulund, AS
AU  - Nybo, M
AU  - Bauer, DC
AU  - Brix, TH
AU  - Hegedüs, L
TI  - The excess risk of major osteoporotic fractures in hypothyroidism is driven by cumulative hyperthyroid as opposed to hypothyroid time: an observational register-based time-resolved cohort analysis
J2  - J Bone Miner Res
PY  - 2015
VL  - 30
SP  - 898
EP  - 905
UR  - https://doi.org/10.1002/jbmr.2416
ER  - 
TY  - JOUR
LB  - 109.
AU  - Händel, MN
AU  - Frederiksen, P
AU  - Cohen, A
AU  - Cooper, C
AU  - Heitmann, BL
AU  - Abrahamsen, B
TI  - Neonatal vitamin D status from archived dried blood spots and future risk of fractures in childhood: results from the D-tect study, a population-based case-cohort study
J2  - Am J Clin Nutr
PY  - 2017
VL  - 106
SP  - 155
EP  - 161
UR  - https://doi.org/10.3945/ajcn.116.145599
ER  - 
TY  - JOUR
LB  - 110.
AU  - Praetorius, K
AU  - Madsen, CM
AU  - Abrahamsen, B
AU  - Jørgensen, HL
AU  - Lauritzen, JB
AU  - Laulund, AS
TI  - Low levels of hemoglobin at admission are associated with increased 30-day mortality in patients with hip fracture
J2  - Geriatr Orthop Surg Rehabil
PY  - 2016
VL  - 7
SP  - 115
EP  - 120
UR  - https://doi.org/10.1177/2151458516647989
ER  - 
TY  - JOUR
LB  - 111.
AU  - Rubin, KH
AU  - Glintborg, D
AU  - Nybo, M
AU  - Andersen, M
AU  - Abrahamsen, B
TI  - Fracture risk is decreased in women with polycystic ovary syndrome: a register-based and population-based cohort study
J2  - J Bone Miner Res
PY  - 2016
VL  - 31
SP  - 709
EP  - 717
UR  - https://doi.org/10.1002/jbmr.2737
ER  - 
TY  - JOUR
LB  - 112.
AU  - Sanni Ali, M
AU  - Ernst, M
AU  - Robinson, DE
AU  - Caskey, F
AU  - Arden, NK
AU  - Ben-Shlomo, Y
TI  - Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B–5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark
J2  - Arch Osteoporos
PY  - 2020
VL  - 15
SP  - 81
UR  - https://doi.org/10.1007/s11657-020-00746-z
ER  - 
TY  - ELEC
LB  - 113.
AU  - The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)
TI  - Guide on Methodological Standards in Pharmacoepidemiology (Revision 5). EMA/95098/2010
UR  - www.encepp.eu/standards_and_guidances/documents/ENCePPGuideofMethStandardsinPE_Rev5.pdf
M1  - November 2018
ER  - 
TY  - JOUR
LB  - 114.
AU  - Prieto-Alhambra, D
AU  - Elorza-Ricart, JM
AU  - Hermosilla, E
AU  - Rodriguez-Ruiz, J
AU  - Mendez-Boo, L
AU  - Medina-Peralta, M
TI  - Primary care prescriptions and subsequent pharmacy dispensing: a population-based study
J2  - Pharmacoepidemiol Drug Saf
PY  - 2014
VL  - 23
SP  - 322
ER  - 
TY  - JOUR
LB  - 115.
AU  - McDonald, HI
AU  - Shaw, C
AU  - Thomas, SL
AU  - Mansfield, KE
AU  - Tomlinson, LA
AU  - Nitsch, D
TI  - Methodological challenges when carrying out research on CKD and AKI using routine electronic health records
J2  - Kidney Int
PY  - 2016
VL  - 90
SP  - 943
EP  - 949
UR  - https://doi.org/10.1016/j.kint.2016.04.010
ER  - 
TY  - JOUR
LB  - 116.
AU  - Moride, Y
AU  - Abenhaim, L
AU  - Yola, M
AU  - Lucein, A
TI  - Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research
J2  - J Clin Epidemiol
PY  - 1994
VL  - 47
SP  - 731
EP  - 737
UR  - https://doi.org/10.1016/0895-4356(94)90170-8
ER  - 
TY  - JOUR
LB  - 117.
AU  - Patorno, E
AU  - Goldfine, AB
AU  - Schneeweiss, S
AU  - Everett, BM
AU  - Glynn, RJ
AU  - Liu, J
AU  - Kim, SC
TI  - Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study
J2  - BMJ
PY  - 2018
VL  - 360
SP  - k119
UR  - https://doi.org/10.1136/bmj.k119
ER  - 
TY  - JOUR
LB  - 118.
AU  - Smerud, KT
AU  - Dolgos, S
AU  - Olsen, IC
AU  - Åsberg, A
AU  - Sagedal, S
AU  - Reisæter, AV
TI  - A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation
J2  - Am J Transplant
PY  - 2012
VL  - 12
SP  - 3316
EP  - 3325
UR  - https://doi.org/10.1111/j.1600-6143.2012.04233.x
ER  - 
TY  - JOUR
LB  - 119.
AU  - Torregrosa, JV
AU  - Fuster, D
AU  - Gentil, MA
AU  - Marcen, R
AU  - Guirado, L
AU  - Zarraga, S
TI  - Open-label trial: effect of weekly risedronate immediately after transplantation in kidney recipients
J2  - Transplantation
PY  - 2010
VL  - 89
SP  - 1476
EP  - 1481
UR  - https://doi.org/10.1097/TP.0b013e3181dc13d0
ER  - 
TY  - JOUR
LB  - 120.
AU  - Walsh, SB
AU  - Altmann, P
AU  - Pattison, J
AU  - Wilkie, M
AU  - Yaqoob, MM
AU  - Dudley, C
TI  - Effect of pamidronate on bone loss after kidney transplantation: a randomized trial
J2  - Am J Kidney Dis
PY  - 2009
VL  - 53
SP  - 856
EP  - 865
UR  - https://doi.org/10.1053/j.ajkd.2008.11.036
ER  - 
TY  - JOUR
LB  - 121.
AU  - Toussaint, ND
AU  - Lau, KK
AU  - Strauss, BJ
AU  - Polkinghorne, KR
AU  - Kerr, PG
TI  - Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial
J2  - Am J Kidney Dis
PY  - 2010
VL  - 56
SP  - 57
EP  - 68
UR  - https://doi.org/10.1053/j.ajkd.2009.12.039
ER  - 
TY  - JOUR
LB  - 122.
AU  - Johansson, H
AU  - Siggeirsdottir, K
AU  - Harvey, NC
AU  - Oden, A
AU  - Gudnason, V
AU  - McCloskey, E
TI  - Imminent risk of fracture after fracture
J2  - Osteoporos Int
PY  - 2017
VL  - 28
SP  - 775
EP  - 780
UR  - https://doi.org/10.1007/s00198-016-3868-0
ER  - 
TY  - JOUR
LB  - 123.
AU  - Kanis, JA
AU  - Johnell, O
AU  - Oden, A
AU  - Johansson, H
AU  - McCloskey, E
TI  - FRAX and the assessment of fracture probability in men and women from the UK
J2  - Osteoporos Int
PY  - 2008
VL  - 19
SP  - 385
EP  - 397
UR  - https://doi.org/10.1007/s00198-007-0543-5
ER  - 
TY  - JOUR
LB  - 124.
AU  - Van Staa, TP
AU  - Abenhaim, L
AU  - Cooper, C
AU  - Zhang, B
AU  - Leufkens, HG
TI  - The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results
J2  - Pharmacoepidemiol Drug Saf
PY  - 2000
VL  - 9
SP  - 359
EP  - 366
UR  - https://doi.org/10.1002/1099-1557(200009/10)9:5<359::AID-PDS507>3.0.CO;2-E
ER  - 
TY  - JOUR
LB  - 125.
AU  - Prieto-Alhambra, D
AU  - Javaid, MK
AU  - Judge, A
AU  - Maskell, J
AU  - Kiran, A
AU  - de Vries, F
TI  - Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use
J2  - Arthritis Rheum
PY  - 2011
VL  - 63
SP  - 992
EP  - 1001
UR  - https://doi.org/10.1002/art.30214
ER  - 
TY  - JOUR
LB  - 126.
AU  - Prieto-Alhambra, D
AU  - Javaid, MK
AU  - Maskell, J
AU  - Judge, A
AU  - Nevitt, M
AU  - Cooper, C
AU  - Arden, NK
TI  - Changes in hip fracture rate before and after total knee replacement due to osteoarthritis: a population-based cohort study
J2  - Ann Rheum Dis
PY  - 2011
VL  - 70
SP  - 134
EP  - 138
UR  - https://doi.org/10.1136/ard.2010.131110
ER  - 
TY  - JOUR
LB  - 127.
AU  - Reginster, J
AU  - Minne, HW
AU  - Sorensen, OH
AU  - Hooper, M
AU  - Roux, C
AU  - Brandi, ML
TI  - Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group
J2  - Osteoporos Int
PY  - 2000
VL  - 11
SP  - 83
EP  - 91
UR  - https://doi.org/10.1007/s001980050010
ER  - 
TY  - JOUR
LB  - 128.
AU  - Davis, S
AU  - Martyn-St James, M
AU  - Sanderson, J
AU  - Stevens, J
AU  - Goka, E
AU  - Rawdin, A
TI  - A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures
J2  - Health Technol Assess
PY  - 2016
VL  - 20
IS  - 78
UR  - https://doi.org/10.3310/hta20780
ER  - 
TY  - JOUR
LB  - 129.
AU  - Abrahamsen, B
AU  - Eiken, P
AU  - Prieto-Alhambra, D
AU  - Eastell, R
TI  - Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study
J2  - BMJ
PY  - 2016
VL  - 353
SP  - i3365
UR  - https://doi.org/10.1136/bmj.i3365
ER  - 
TY  - JOUR
LB  - 130.
AU  - Prieto-Alhambra, D
AU  - Javaid, MK
AU  - Judge, A
AU  - Maskell, J
AU  - Kiran, A
AU  - Cooper, C
TI  - Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis
J2  - Osteoporos Int
PY  - 2011
VL  - 22
SP  - 1555
EP  - 1571
UR  - https://doi.org/10.1007/s00198-010-1368-1
ER  - 
TY  - JOUR
LB  - 131.
AU  - Erviti, J
AU  - Alonso, A
AU  - Gorricho, J
AU  - Lopez, A
TI  - Oral bisphosphonates may not decrease hip fracture risk in elderly Spanish women: a nested case-control study
J2  - BMJ Open
PY  - 2013
VL  - 3
SP  - e002084
UR  - https://doi.org/10.1136/bmjopen-2012-002084
ER  - 
TY  - JOUR
LB  - 132.
AU  - Real, J
AU  - Galindo, G
AU  - Galván, L
AU  - Lafarga, MA
AU  - Rodrigo, MD
AU  - Ortega, M
TI  - Use of oral bisphosphonates in primary prevention of fractures in postmenopausal women: a population-based cohort study
J2  - PLOS ONE
PY  - 2015
VL  - 10
SP  - e0118178
UR  - https://doi.org/10.1371/journal.pone.0118178
ER  - 

LB  - 133.
AU  - He, Y
AU  - Reyes, C
AU  - Lapi, F
AU  - Simonetti, M
AU  - Rijnbeek, P
AU  - Van der Lei, J
TI  - A multi-database, multinational validation study of cardiovascular death, venous thromboembolic events and gastrointestinal diseases in the EU-ADR Alliance
T2  - International Society for Pharmaeconomics and Outcomes Research (ISPOR)
CY  - Europe, Barcelona, Spain
DA  - November 2018
ER  - 
TY  - JOUR
LB  - 134.
AU  - Edwards, BJ
AU  - Usmani, S
AU  - Raisch, DW
AU  - McKoy, JM
AU  - Samaras, AT
AU  - Belknap, SM
TI  - Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) project
J2  - J Oncol Pract
PY  - 2013
VL  - 9
SP  - 101
EP  - 106
UR  - https://doi.org/10.1200/JOP.2011.000486
ER  - 
TY  - JOUR
LB  - 135.
AU  - Komada, T
AU  - Morishita, Y
AU  - Kitamura, M
AU  - Iwazu, K
AU  - Numata, A
AU  - Kobayashi, T
TI  - Acute kidney injury in a patient with nephrotic syndrome due to focal segmental glomerular nephritis induced by a single oral administration of high-dose bisphosphonate (minodronate)
J2  - Intern Med
PY  - 2013
VL  - 52
SP  - 1383
EP  - 1387
UR  - https://doi.org/10.2169/internalmedicine.52.0094
ER  - 
TY  - JOUR
LB  - 136.
AU  - Peña de la Vega, L
AU  - Fervenza, FC
AU  - Lager, D
AU  - Habermann, T
AU  - Leung, N
TI  - Acute granulomatous interstitial nephritis secondary to bisphosphonate alendronate sodium
J2  - Ren Fail
PY  - 2005
VL  - 27
SP  - 485
EP  - 489
UR  - https://doi.org/10.1081/JDI-65397
ER  - 
TY  - JOUR
LB  - 137.
AU  - Shih, AW
AU  - Weir, MA
AU  - Clemens, KK
AU  - Yao, Z
AU  - Gomes, T
AU  - Mamdani, MM
TI  - Oral bisphosphonate use in the elderly is not associated with acute kidney injury
J2  - Kidney Int
PY  - 2012
VL  - 82
SP  - 903
EP  - 908
UR  - https://doi.org/10.1038/ki.2012.227
ER  - 
TY  - JOUR
LB  - 138.
AU  - Ali, M
AU  - Robinson, D
AU  - Pallares, N
AU  - Tebe, C
AU  - Cooper, C
AU  - Abrahamsen, B
TI  - The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
J2  - Pharmacoepidemiol Drug Saf
PY  - 2018
VL  - 27
SP  - 184
ER  - 
TY  - JOUR
LB  - 139.
AU  - Moe, SM
AU  - Drüeke, TB
AU  - Block, GA
AU  - Cannata-Andía, JB
AU  - Elder, GJ
AU  - Fukagawa, M
TI  - Kidney Disease: Improving Global Outcomes CKDMBDWG. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
J2  - Kidney Int Suppl
PY  - 2009
VL  - 188
SP  - S1
EP  - 130
UR  - https://doi.org/10.1038/ki.2009.188
ER  - 
TY  - JOUR
LB  - 140.
AU  - Kreutle, V
AU  - Blum, C
AU  - Meier, C
AU  - Past, M
AU  - Müller, B
AU  - Schütz, P
AU  - Borm, K
TI  - Bisphosphonate induced hypocalcaemia – report of six cases and review of the literature
J2  - Swiss Med Wkly
PY  - 2014
VL  - 144
SP  - w13979
UR  - https://doi.org/10.4414/smw.2014.13979
ER  - 
TY  - JOUR
LB  - 141.
AU  - Do, WS
AU  - Park, JK
AU  - Park, MI
AU  - Kim, HS
AU  - Kim, SH
AU  - Lee, DH
TI  - Bisphosphonate-induced severe hypocalcemia – a case report
J2  - J Bone Metab
PY  - 2012
VL  - 19
SP  - 139
EP  - 145
UR  - https://doi.org/10.11005/jbm.2012.19.2.139
ER  - 
TY  - JOUR
LB  - 142.
AU  - Vouri, SM
AU  - Alvarez, CA
AU  - Blaszczyk, AT
TI  - Effects of oral bisphosphonate therapy on serum calcium in elderly veterans with poor kidney function
J2  - Am J Geriatr Pharmacother
PY  - 2012
VL  - 10
SP  - 178
EP  - 184
UR  - https://doi.org/10.1016/j.amjopharm.2012.04.001
ER  - 
TY  - JOUR
LB  - 143.
AU  - Bell, KJ
AU  - Hayen, A
AU  - Macaskill, P
AU  - Irwig, L
AU  - Craig, JC
AU  - Ensrud, K
AU  - Bauer, DC
TI  - Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data
J2  - BMJ
PY  - 2009
VL  - 338
SP  - b2266
UR  - https://doi.org/10.1136/bmj.b2266
ER  - 
TY  - JOUR
LB  - 144.
AU  - Harris, ST
AU  - Watts, NB
AU  - Genant, HK
AU  - McKeever, CD
AU  - Hangartner, T
AU  - Keller, M
TI  - Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group
J2  - JAMA
PY  - 1999
VL  - 282
SP  - 1344
EP  - 1352
UR  - https://doi.org/10.1001/jama.282.14.1344
ER  - 
TY  - JOUR
LB  - 145.
AU  - Rubin, KH
AU  - Abrahamsen, B
AU  - Hermann, AP
AU  - Bech, M
AU  - Gram, J
AU  - Brixen, K
TI  - Prevalence of risk factors for fractures and use of DXA scanning in Danish women. A regional population-based study
J2  - Osteoporos Int
PY  - 2011
VL  - 22
SP  - 1401
EP  - 1409
UR  - https://doi.org/10.1007/s00198-010-1348-5
ER  - 
TY  - JOUR
LB  - 146.
AU  - Eastell, R
AU  - Devogelaer, JP
AU  - Peel, NF
AU  - Chines, AA
AU  - Bax, DE
AU  - Sacco-Gibson, N
TI  - Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patients
J2  - Osteoporos Int
PY  - 2000
VL  - 11
SP  - 331
EP  - 337
UR  - https://doi.org/10.1007/s001980070122
ER  - 
TY  - JOUR
LB  - 147.
AU  - Liberman, UA
AU  - Weiss, SR
AU  - Bröll, J
AU  - Minne, HW
AU  - Quan, H
AU  - Bell, NH
TI  - Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group
J2  - N Engl J Med
PY  - 1995
VL  - 333
SP  - 1437
EP  - 1443
UR  - https://doi.org/10.1056/NEJM199511303332201
ER  - 
TY  - JOUR
LB  - 148.
AU  - Block, GA
AU  - Bone, HG
AU  - Fang, L
AU  - Lee, E
AU  - Padhi, D
TI  - A single-dose study of denosumab in patients with various degrees of renal impairment
J2  - J Bone Miner Res
PY  - 2012
VL  - 27
SP  - 1471
EP  - 1479
UR  - https://doi.org/10.1002/jbmr.1613
ER  - 
TY  - JOUR
LB  - 149.
AU  - Alarkawi, D
AU  - Bliuc, D
AU  - Pallares, N
AU  - Tebe, C
AU  - Cooper, C
AU  - Caskey, F
TI  - Oral bisphosphonate use and all-cause mortality in patients with advanced (stage IIIB+) chronic kidney disease: a propensity score analysis
J2  - Pharmacoepidemiol Drug Saf
PY  - 2018
VL  - 27
SP  - 185
ER  -